Top Medical Stocks To Watch Now – February 05th

Eli Lilly and Company, UnitedHealth Group, Tempus AI, Merck & Co., Inc., Amgen, Novo Nordisk A/S, and Walmart are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks refer to stocks of companies that operate in the healthcare or pharmaceutical industry. These companies are involved in researching, developing, manufacturing, and selling medical products, equipment, treatments, or services. Investing in medical stocks can provide exposure to a sector with the potential for growth driven by advancements in healthcare technology and an aging population. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY traded up $19.21 during trading hours on Wednesday, reaching $845.28. 2,260,170 shares of the company traded hands, compared to its average volume of 3,753,855. The stock has a market capitalization of $802.44 billion, a PE ratio of 91.26, a price-to-earnings-growth ratio of 1.72 and a beta of 0.42. Eli Lilly and Company has a fifty-two week low of $691.10 and a fifty-two week high of $972.53. The company has a quick ratio of 0.97, a current ratio of 1.27 and a debt-to-equity ratio of 2.03. The stock has a fifty day simple moving average of $785.46 and a 200 day simple moving average of $843.28.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

UNH traded down $9.24 during midday trading on Wednesday, hitting $536.22. The company’s stock had a trading volume of 2,507,171 shares, compared to its average volume of 4,370,820. The firm has a 50-day moving average price of $533.81 and a two-hundred day moving average price of $564.94. The firm has a market cap of $493.47 billion, a P/E ratio of 34.61, a PEG ratio of 1.48 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 52-week low of $436.38 and a 52-week high of $630.73.

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

NASDAQ:TEM traded up $7.54 during mid-day trading on Wednesday, hitting $69.39. The company had a trading volume of 17,932,202 shares, compared to its average volume of 11,074,773. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI has a 1 year low of $22.89 and a 1 year high of $79.49. The business has a fifty day simple moving average of $44.20 and a 200-day simple moving average of $48.58.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of Merck & Co., Inc. stock traded down $0.64 on Wednesday, hitting $90.10. 10,157,486 shares of the company’s stock traded hands, compared to its average volume of 12,754,146. The stock has a market cap of $227.92 billion, a P/E ratio of 18.85, a PEG ratio of 1.20 and a beta of 0.38. The firm’s 50-day moving average is $99.58 and its 200 day moving average is $107.12. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79. Merck & Co., Inc. has a 52-week low of $87.33 and a 52-week high of $134.63.

Amgen (AMGN)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout.

Shares of NASDAQ AMGN traded up $15.85 during midday trading on Wednesday, hitting $304.87. The company’s stock had a trading volume of 2,989,658 shares, compared to its average volume of 3,124,645. Amgen has a 1-year low of $253.30 and a 1-year high of $346.85. The company has a debt-to-equity ratio of 7.55, a quick ratio of 0.96 and a current ratio of 1.32. The firm’s fifty day moving average price is $271.14 and its 200-day moving average price is $303.52. The firm has a market cap of $163.88 billion, a P/E ratio of 39.04, a P/E/G ratio of 2.87 and a beta of 0.56.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NYSE:NVO traded up $3.88 on Wednesday, hitting $86.50. The company’s stock had a trading volume of 9,056,927 shares, compared to its average volume of 9,280,718. Novo Nordisk A/S has a 12 month low of $78.17 and a 12 month high of $148.15. The company has a market capitalization of $388.18 billion, a price-to-earnings ratio of 28.05, a price-to-earnings-growth ratio of 0.93 and a beta of 0.45. The stock’s 50-day moving average is $92.65 and its two-hundred day moving average is $112.19. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.75 and a current ratio of 0.94.

Walmart (WMT)

Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.

Shares of NYSE:WMT traded up $1.08 on Wednesday, reaching $101.85. 6,700,732 shares of the company traded hands, compared to its average volume of 14,948,494. The company’s 50 day moving average is $93.46 and its 200-day moving average is $83.69. Walmart has a fifty-two week low of $55.85 and a fifty-two week high of $102.23. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.85 and a quick ratio of 0.23. The stock has a market capitalization of $818.18 billion, a PE ratio of 41.72, a P/E/G ratio of 4.49 and a beta of 0.55.